The world's first large-scale AI factory has been put into operation, equipped with over 1000 GPUs. The significance of this information is very important. The fact that pharmaceutical companies are starting to build AI factories essentially indicates a trend: pharmaceutical research and development is transitioning from experimental science to computational science. The pharmaceutical industry has entered a computational arms race, just like AI companies. The AI factories of pharmaceutical companies are essentially accelerating humanity's ability to crack the code of diseases, and they indeed have the potential to significantly advance the process of extending human lifespan. The three biggest impacts of AI on lifespan extension 1. Breakthroughs in cancer will come faster 2. Age-related diseases may be solved 3. Research on delaying aging will accelerate Without AI: many medical breakthroughs may take 30–50 years. With AI: it may take 10–20 years. In other words: many treatments that were originally expected to appear in 2050 may emerge as early as 2035.